skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Leridistim (Code C1846)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Leridistim

Definition: A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF) receptors, thereby stimulating the production and maturation of neutrophils, platelets, and lymphocytes after chemotherapy. (NCI04)

NCI-GLOSS Definition: A substance that is being studied for its ability to stimulate the production of blood cells during chemotherapy. It belongs to the family of drugs called colony-stimulating factors.

Label: Leridistim

NCI Thesaurus Code: C1846 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0919350  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)

External Source Codes: 
CAS Registry Number 193700-51-5 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 43477
PDQ Open Trial Search ID 43477 (check for NCI PDQ open clinical trial info)
UMLS CUI C0919350

Other Properties:
     Name Value (qualifiers indented underneath)
code C1846
Legacy_Concept_Name Leridistim
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom